FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

U Schühly

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Phenomena

Metabolic Clearance Rate

Anatomy

Saliva

Physiology

Drug Interactions

Register to see full profile

Co-author Network

Co-Publications
Name
3
Heino Stass
2
D Kubitza
1
JG Möller
1
Axel Dalhoff
1
H Delesen

Register to see all co-authors

Publications

TOP 3
Heino Stass; U Schühly; JG Möller; H Delesen
Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
Heino Stass; D Kubitza; U Schühly
Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
Heino Stass; Axel Dalhoff; D Kubitza; U Schühly
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of U Schühly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2001: Heino Stass; U Schühly; JG Möller; H Delesen
Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers.
Clinical pharmacokinetics 2001;40 Suppl 1():49-55.
2001: Heino Stass; D Kubitza; U Schühly
Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration.
Clinical pharmacokinetics 2001;40 Suppl 1():1-9.
1998: Heino Stass; Axel Dalhoff; D Kubitza; U Schühly
Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
Antimicrobial agents and chemotherapy 1998;42(8):2060-5.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.